 | Related Articles |
Pharmaceutical Approval Update.
P T. 2018 Apr;43(4):205-227
Authors: Choy M
Abstract
Netarsudil ophthalmic solution (Rhopressa) for the reduction of elevated intraocular pressure; ertugliflozin (Steglatro) for adults with type-2 diabetes; and lutetium lu 177 dotatate (Lutathera) for certain gastroenteropancreatic neuroendocrine tumors.
PMID: 29622939 [PubMed]